Looking at BLPH go from $3.39-$25+ just on approva
Post# of 148282
(Total Views: 369)
Posted On: 03/20/2020 11:04:27 AM
Looking at BLPH go from $3.39-$25+ just on approval of testing makes me sad.
How many PR's have we put out on approval to start testing? We have Phase 3 trails, we have several Phase 2 trials, and approval for others.
Other companies with much less progression are doing much better. I believe in the science as the FDA wouldn't keep allowing us to advance, so now the questions is, where is the bottle neck? What is keeping us from advancing?
I don't believe this new PR firm is doing a great job, and I don't believe NP should be the face of Cytodyn. He has broken too many deadlines, as others have mentioned the credibility is gone. Not to mention the salary increases and bonuses, with out any solid progressions. Let the new CMO do the talking for a while, so he can speak to the science, those proactive videos do not present a professional image. We need to travel to places to do in person interviews like they have done in the past.
We should be off the OTC now.
How many PR's have we put out on approval to start testing? We have Phase 3 trails, we have several Phase 2 trials, and approval for others.
Other companies with much less progression are doing much better. I believe in the science as the FDA wouldn't keep allowing us to advance, so now the questions is, where is the bottle neck? What is keeping us from advancing?
I don't believe this new PR firm is doing a great job, and I don't believe NP should be the face of Cytodyn. He has broken too many deadlines, as others have mentioned the credibility is gone. Not to mention the salary increases and bonuses, with out any solid progressions. Let the new CMO do the talking for a while, so he can speak to the science, those proactive videos do not present a professional image. We need to travel to places to do in person interviews like they have done in the past.
We should be off the OTC now.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼